|
CARDIFF-BY-THE-SEA, Calif., March 16, 2026 /PRNewswire/ -- Field Medical, Inc., a clinical-stage medical technology company advancing second-generation pulsed field ablation (PFA) solutions for complex ventricular and atrial arrhythmias, today announced the appointment of Mark A. Turco, MD, as chief executive officer, effective immediately.
Dr. Turco brings more than 30 years of leadership experience spanning venture-backed cardiovascular startups and executive roles within large-cap medical device organizations. He has led multiple clinical-stage companies through development and strategic transactions, building organizations positioned for long-term scale.
"Mark's unique background as a cardiologist, clinical trialist and an experienced medical device executive equips him well to guide Field Medical through this next phase of growth," said Ben Cannon, board member of Field Medical and member of the BioStar Capital and Cue Growth investment teams. "As we accelerate our clinical programs and strengthen our operational capabilities, his executive experience in advancing complex medical technologies across development, regulatory and commercialization milestones will enable disciplined execution and sustainable long-term value creation."
Dr. Turco served as president and CEO of JC Medical, Inc., where he led development of a dedicated transcatheter aortic valve replacement (TAVR) system for aortic regurgitation that was acquired by Edwards Lifesciences in July 2024. Prior to that, he held senior leadership roles at Medtronic and Covidien, serving as vice president and chief medical officer of the vascular and neurovascular franchises, and most recently served as president and CEO of the Rhode Island Life Science Hub. A board-certified interventional cardiologist prior to transitioning to industry, Dr. Turco brings both clinical insight and operational experience to the leadership of Field Medical.
"I am honored to join Field Medical at this pivotal moment in its evolution," said Dr. Turco. "The company has built a differentiated PFA platform with the potential to meaningfully address significant unmet patient needs in both ventricular arrhythmias and atrial fibrillation. I look forward to partnering closely with the exceptional Field Medical team to rigorously advance our clinical programs and navigate regulatory pathways to meet our operational goals."
About Field Medical®, Inc.
Founded in 2022, Field Medical is a clinical-stage medical technology company committed to advancing pulsed field ablation (PFA) solutions for complex cardiac arrhythmias. Its FieldForce Ablation System integrates a focal catheter design with proprietary FieldBending™ energy designed to safely deliver efficient, precise ablation with the goal of improving outcomes in ventricular and atrial arrhythmia treatment. In 2024, Field Medical earned Breakthrough Device Designation and gained entry into the FDA TAP Pilot Program for its ventricular tachycardia indication. In October 2025, the VCAS trial was published in Circulation.
For more information, visit www.fieldmedicalinc.com and follow us on LinkedIn, X, and YouTube.
The FieldForce™ Ablation System is an investigational device and is limited by federal (or United States) law to investigational use.
Media Contact
Holly Windler
619.929.1275
media@fieldmedicalinc.com
Photo - https://mma.prnasia.com/media2/2933749/Field_Medical_new_CEO_Dr_Mark_A_Turco.jpg?p=medium600
Logo - https://mma.prnasia.com/media2/2574173/Field_Medical_Logo_Block_WhiteOnBlack_Logo.jpg?p=medium600
CARDIFF-BY-THE-SEA, Calif., March 16, 2026 /PRNewswire/ -- Field Medical, Inc., a clinical-stage medical technology company advancing second-generation pulsed field ablation (PFA) solutions for complex ventricular and atrial arrhythmias, today announced the appointment of Mark A. Turco, MD, as chief executive officer, effective immediately.
Dr. Turco brings more than 30 years of leadership experience spanning venture-backed cardiovascular startups and executive roles within large-cap medical device organizations. He has led multiple clinical-stage companies through development and strategic transactions, building organizations positioned for long-term scale.
"Mark's unique background as a cardiologist, clinical trialist and an experienced medical device executive equips him well to guide Field Medical through this next phase of growth," said Ben Cannon, board member of Field Medical and member of the BioStar Capital and Cue Growth investment teams. "As we accelerate our clinical programs and strengthen our operational capabilities, his executive experience in advancing complex medical technologies across development, regulatory and commercialization milestones will enable disciplined execution and sustainable long-term value creation."
Dr. Turco served as president and CEO of JC Medical, Inc., where he led development of a dedicated transcatheter aortic valve replacement (TAVR) system for aortic regurgitation that was acquired by Edwards Lifesciences in July 2024. Prior to that, he held senior leadership roles at Medtronic and Covidien, serving as vice president and chief medical officer of the vascular and neurovascular franchises, and most recently served as president and CEO of the Rhode Island Life Science Hub. A board-certified interventional cardiologist prior to transitioning to industry, Dr. Turco brings both clinical insight and operational experience to the leadership of Field Medical.
"I am honored to join Field Medical at this pivotal moment in its evolution," said Dr. Turco. "The company has built a differentiated PFA platform with the potential to meaningfully address significant unmet patient needs in both ventricular arrhythmias and atrial fibrillation. I look forward to partnering closely with the exceptional Field Medical team to rigorously advance our clinical programs and navigate regulatory pathways to meet our operational goals."
About Field Medical®, Inc.
Founded in 2022, Field Medical is a clinical-stage medical technology company committed to advancing pulsed field ablation (PFA) solutions for complex cardiac arrhythmias. Its FieldForce Ablation System integrates a focal catheter design with proprietary FieldBending™ energy designed to safely deliver efficient, precise ablation with the goal of improving outcomes in ventricular and atrial arrhythmia treatment. In 2024, Field Medical earned Breakthrough Device Designation and gained entry into the FDA TAP Pilot Program for its ventricular tachycardia indication. In October 2025, the VCAS trial was published in Circulation.
For more information, visit www.fieldmedicalinc.com and follow us on LinkedIn, X, and YouTube.
The FieldForce™ Ablation System is an investigational device and is limited by federal (or United States) law to investigational use.
Media Contact
Holly Windler
619.929.1275
media@fieldmedicalinc.com
Photo - https://mma.prnasia.com/media2/2933749/Field_Medical_new_CEO_Dr_Mark_A_Turco.jpg?p=medium600
Logo - https://mma.prnasia.com/media2/2574173/Field_Medical_Logo_Block_WhiteOnBlack_Logo.jpg?p=medium600
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Field Medical Names Mark A. Turco, MD, as Chief Executive Officer
LOS ANGELES, March 16, 2026 /PRNewswire/ -- Halara, the leading athleisure brand announces the launch of the Halara x Reece Weaver Edit, a curated selection of Reece's favorite Halara styles designed to support everyday movement, self-expression, and confidence with ease through every dance. Launching March 16 exclusively on Halara.com, the edit invites women everywhere to Dance Your Way, embracing freedom, comfort, and individuality in every moment.
"As a dancer, movement is everything to me," says Reece Weaver. "I chose the styles I genuinely reach for every day - pieces that make me feel supported, confident, and free to move. When you feel comfortable in what you're wearing, you can truly dance your way through anything."
The Halara x Reece Weaver Edit spotlights the pieces Reece reaches for again and again - versatile, supportive styles that transition effortlessly from studio to street. Each selection reflects her approach to movement: confident, expressive, and grounded in ease.
Behind the scene video: https://youtu.be/D4T6mvw0u50
Dance Your Way
This edit is about making movement feel natural and empowered. Whether running errands, navigating busy workdays, traveling, unwinding with friends, or stepping into the studio, these hand-selected styles are designed to move with you offering supportive flexibility without restriction or hesitation.
Because anywhere can be center stage.
Reece's Go-To Halara Favorites
The Halara x Reece Weaver Edit brings together 50 versatile Halara pieces personally selected by Reece Weaver. From buttery-soft SoftlyZero™ Active Dresses to shaping UltraSculpt™ leggings and stretch-infused Flex™ Denim, the edit highlights styles that deliver comfort, support, and everyday ease.
Priced between $30–$80, the edit makes Reece's go-to Halara essentials accessible for women ready to move confidently in their own rhythm.
Why This Collaboration
Halara and Reece Weaver share a belief that movement should feel joyful, authentic, and accessible. Centered around the curated Halara x Reece Weaver Edit, the partnership highlights the Halara pieces Reece genuinely reaches for styles that support her life as a dancer and move effortlessly through everyday moments. Together, the collaboration celebrates confidence, self-expression, and ease in motion.
As part of the partnership, Reece will collaborate with Halara on a dedicated series of videos showcasing the versatility of the Edit, spotlighting its stretchy, breathable, and movement-friendly designs. Through dynamic styling and real-life wear, she will demonstrate how the pieces transition seamlessly from everyday wear to active moments. Reece will also attend select events with Halara throughout the year, further bringing the Edit to life and connecting with the community in meaningful ways.
The Halara x Reece Weaver Edit launches March 16, 2026 at https://www.halara.com/activity/reece-weaver-edit.
Follow along and share your movement moments using #DanceYourWay and #HalaraxReece.
About Halara
Halara is a leading athleisure brand that blends stylish design with innovative fabrics for comfortable, versatile activewear that performs. Halara empowers confidence with styles that are made for what moves you from the studio to the streets. Committed to affordability, inclusivity, and high-quality materials, Halara continues to redefine athleisure to support every wellness goal. Learn more at www.halara.com or follow @halara_official on Instagram
CONTACT: press@halara.com
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Dance Your Way: The Halara x Reece Weaver Edit Celebrates Movement and Ease
